Adell A (2004). Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms? Curr Drug Targets CNS Neurol Disord 3: 113–121.
Bilkei-Gorzo A, Racz I, Michel K, Zimmer A (2002). Diminished anxiety- and depression-related behaviors in mice with selective deletion of the Tac1 gene. J Neurosci 22: 10046–10052.
Blier P, Gobbi G, Haddjeri N, Santarelli L, Mathew G, Hen R (2004). Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response. J Psychiatry Neurosci 29: 208–218.
Bondi CO, Barrera G, Lapiz MD, Bedard T, Mahan A, Morilak DA (2007). Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine. Prog Neuropsychopharmacol Biol Psychiatry 31: 482–495.
Burgdorf J, Panksepp J (2006). The neurobiology of positive emotions. Neurosci Biobehav Rev 30: 173–187.
Chen LW, Wei LC, Liu HL, Qiu Y, Chan YS (2001). Cholinergic neurons expressing substance P receptor (NK(1)) in the basal forebrain of the rat: a double immunocytochemical study. Brain Res 904: 161–166.
Chenu F, Guiard BP, Bourin M, Gardier AM (2006). Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test. Behav Brain Res 172: 256–263.
Conley RK, Cumberbatch MJ, Mason GS, Williamson DJ, Harrison T, Locker K et al (2002). Substance P (neurokinin 1) receptor antagonists enhance dorsal raphe neuronal activity. J Neurosci 22: 7730–7736.
Corti C, Aldegheri L, Somogyi P, Ferraguti F (2002). Distribution and synaptic localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS. Neuroscience 110: 403–420.
Cryan JF, Valentino RJ, Lucki I (2005). Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29: 547–569.
Culman J, Unger T (1995). Central tachykinins: mediators of defence reaction and stress reactions. Can J Physiol Pharmacol 73: 885–891.
Dableh LJ, Yashpal K, Rochford J, Henry JL (2005). Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat. Eur J Pharmacol 507: 99–105.
David DJ, Froger N, Guiard B, Przybylski C, Jego G, Boni C et al (2004). Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice. Eur J Pharmacol 492: 41–48.
De Vry J, Schreiber R, Melon C, Dalmus M, Jentzsch KR (2004). 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. Eur Neuropsychopharmacol 14: 487–495.
Doutrelant O, Poulain P, Carette B (1993). Comparative distribution of calbindin and Met-enkephalin immunoreactivities in the guinea-pig lateral septum, with reference to electrophysiologically characterized neurons in the mediolateral part. Brain Res 615: 335–341.
Ebner K, Rupniak NM, Saria A, Singewald N (2004). Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats. Proc Natl Acad Sci USA 101: 4280–4285.
Ebner K, Singewald N (2006). The role of substance P in stress and anxiety responses. Amino Acids 31: 251–272.
Ferraguti F, Cobden P, Pollard M, Cope D, Shigemoto R, Watanabe M et al (2004). Immunolocalization of metabotropic glutamate receptor 1alpha (mGluR1alpha) in distinct classes of interneuron in the CA1 region of the rat hippocampus. Hippocampus 14: 193–215.
